From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

According to the FDA, while allergic reactions to color additives are rare, dyes must be included in product labels.

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital ...

V Men’s multivitamin is being recalled due to undeclared soy, a potential allergen, according to the FDA. Here’s a list of ...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug ...

Dozens of generic medications—including some to treat conditions like high blood pressure, allergies, and high ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

Over 1,700 pounds of Cabot Creamery Butter may have been contaminated with fecal bacteria. See if you bought it in NJ, ...

U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as sources say recent layoffs have had ...

Sanofi’s oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib has gained US Food and Drug Administration (FDA) orphan drug designation ... to pursuing potential first and ...

The FDA granted Priority Review to Apellis' sNDA ... Cites Longer Peak Sales Timing For Syfovre The Prescription Drug User Fee Act (PDUFA) target action date is July 28, 2025.